Moving medicine at the speed of need

By transforming complex data into actionable insights, we empower our partners to accelerate discovery, improve patient outcomes, and redefine the future of healthcare, one genome at a time.

Faster genomics lead to faster care

Velsera advances medicine as one of the largest omics analytics providers. Our cutting-edge technology accelerates outcomes, ensuring new treatments and drugs reach the market faster and clinical care scales more efficiently.

Disconnected data prevents progress

The current pace of precision medicine is moving too slowly and inefficiently, not from a lack of data or expertise, but because isolated and incompatible data block collaboration. This fragmentation disrupts efforts to conquer complex diseases and slows medical innovations.

Unified data powers progress

Our platform allows researchers to drive medical innovation throughout the precision medicine cycle, from identifying unmet needs to scaling successful treatments. This ultimately improves patient outcomes.

Velsera pushes medicine forward

As one of the largest omics analytics providers in the market

8/10

Top pharmas supported by our technology-enabled products and services

350+

Clinical labs across our global partnership network and growing

100M+

Clinical test results automated through our platforms

Testimonials

Hear why 8 out of 10 top pharmas trust our tech to move medicine forward at record speed.

Velsera has been a great partner enabling our NGS offering so we can improve the quality and speed of patient care. With Velsera's team and technology, we have been able to streamline our workflow and customize our clinical report. We can run various assays using the single Velsera platform. And our physicians are highly complementary of the report we created with Velsera given the content and aesthetic.

Jen Gass

Associate Director, Genetics Laboratory / Florida Cancer Specialists

The Clinical Genomics Workspace (CGW) by Velsera has provided our laboratory with a seamless, integrated software solution that allows us to spend more time analyzing the sequencing data and generating clinical reports and less time worrying about logistics.

James Patrick Solomon, M.D., Ph.D.

Medical Director, Clinical Genomics Laboratory / Weill Cornell Medicine

Trusted widely across the industry

People

Powering the potential of precision medicine

Jamie Littlejohns

Chief Executive Officer

Jamie joined Velsera in January 2024, having previously provided external support to Velsera and their founding business since early 2022. He has worked in healthcare and life sciences since 2010 and previously was a Partner at McKinsey & Company where he spent over a decade and led their Health & Life Science Investing Practice in Europe, specializing in supporting investor-backed health & life science tech businesses on their scale-up journeys.

Guy Emslie

Chief Financial Officer

Guy Emslie is the Chief Financial Officer at Velsera, bringing over 15 years of financial leadership experience in scaling technology-driven businesses. With a strong background in enterprise software, SaaS, and tech services, Guy has a proven track record of driving financial strategy and growth in dynamic, high-tech environments.

Julie Furt

Chief Customer Officer

Julie has extensive experience managing high-growth, high-performing global customer success teams and has worked with clients across a variety of industries, including life sciences, healthcare, and government. She has particular interest in nurturing partnerships with clients, customer success management, and customer value realization.

Jim Lee

Chief Commercial Officer

Jim is a passionate commercial officer with extensive experience in the life sciences sector, dedicated to driving advancements in patient care. Adept leader in operations and revenue generation within the dynamic and competitive life sciences industry. He has worked in healthcare and life sciences since 2008 and was Vice President of Sales at Clarivate where he spent over a decade and led their Health & Life Science Commercial Group globally, specializing in scaling customer facing teams.

John Patrick

Chief Technology Officer

JP brings extensive experience in product development, software engineering and secure cloud hosting to Velsera. Most recently, he was the EVP of engineering at TalentReef, and beforehand he was the SVP of product development and cloud hosting services at Bioclinica.

Nathan Baird

Chief Product Officer

Nate has deep experience in product portfolio strategy, financial analysis and next-generation sequencing product development, as well as an extensive academic research background in molecular genetics and genomics. Prior to joining Velsera, he worked at Illumina for more than eight years.

We're hiring!

Velsera offers a compelling, flexible work environment with a team of diverse mission-driven employees from around the globe. If you have an interest in working for an organization with great values that is truly making a difference within science and healthcare, you have come to the right place!  

Better data, better lives—in record time

We’re on a mission to build a future where diseases are detected earlier, treated more effectively, and ultimately defeated.